Thinking translational: Things to consider in CAR T cell research workflows

Developing safe and effective CAR T cell therapies is a challenging task. That’s why thinking translational early in research experiments is important. Suitable tools will later enable a smooth transition from small-scale to large-scale workflows.

Join us as we discuss how to set up your small-scale research workflow to ease up the transition to large-scale manufacturing in preclinical development.

• Learn about key considerations for every step of your workflow including cell separation, culture, and analysis
• Get to know solutions specially developed for a smooth transition to cell manufacturing
• What´s new? – Latest developments for CAR T cell research and manufacturing

Saskia Rösch PhD

Global Product Manager at Miltenyi Biotec

Saskia Roesch, PhD, received her doctoral degree in Biology from the University of Heidelberg/DKFZ, Germany, in 2017. She continued her studies in Cancer Immunotherapy as a postdoctoral fellow at the University Hospital in Heidelberg, Germany, before joining Miltenyi Biotec as a Global Product Manager for T Cell Immunology and Gene-engineered T cells.

Watch now

SPEAKERS

Saskia Rösch PhD

Global Product Manager at Miltenyi Biotec

You might also like

Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME

Emily Neil, Ariadna Pascual

27 June

in 64

Days

Register

Precision in production: optimizing monitoring and quality control for high-value plasmids

Oleksandr Karpenko

6 June

in 43

Days

Register

Advancing cell therapy: innovations in polymer-based encapsulation and delivery

B Yevgeniy, O Veiseh, M Delic-Schlumbohm et al.

5 June

in 42

Days

Register

Pure and simple: understanding LNP analytics for better mRNA-based drugs

Adam Crowe

29 May

in 35

Days

Register

Empowering patient care: in-process and quality control solutions for cellular therapies

Christin Tischner, Simon Lennartz

23 May

in 29

Days

Register